These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 1777549
21. Omeprazole vs. ranitidine in the short-term treatment of duodenal ulcer: an Italian multicenter study. Barbara L, Blasi A, Cheli R, Corinaldesi R, Dobrilla G, Francavilla A, Rinetti M, Vezzaldini P, Abbiati R, Gradnik R. Hepatogastroenterology; 1987 Oct; 34(5):229-32. PubMed ID: 3315923 [Abstract] [Full Text] [Related]
22. Omeprazole or ranitidine in long-term treatment of reflux esophagitis. The Scandinavian Clinics for United Research Group. Hallerbäck B, Unge P, Carling L, Edwin B, Glise H, Havu N, Lyrenäs E, Lundberg K. Gastroenterology; 1994 Nov; 107(5):1305-11. PubMed ID: 7926494 [Abstract] [Full Text] [Related]
23. Factors Associated With Response to Teduglutide in Patients With Short-Bowel Syndrome and Intestinal Failure. Jeppesen PB, Gabe SM, Seidner DL, Lee HM, Olivier C. Gastroenterology; 2018 Mar; 154(4):874-885. PubMed ID: 29174926 [Abstract] [Full Text] [Related]
24. The influence of dietary fat on jejunostomy output in patients with severe short bowel syndrome. Ovesen L, Chu R, Howard L. Am J Clin Nutr; 1983 Aug; 38(2):270-7. PubMed ID: 6410899 [Abstract] [Full Text] [Related]
25. Review article: practical management of the short bowel. Lennard-Jones JE. Aliment Pharmacol Ther; 1994 Dec; 8(6):563-77. PubMed ID: 7696444 [Abstract] [Full Text] [Related]
26. Comparison between ranitidine and omeprazole for protection against gastroduodenal damage caused by naproxen. Oddsson E, Gudjónsson H, Thjódleifsson B. Scand J Gastroenterol; 1992 Dec; 27(12):1045-8. PubMed ID: 1475621 [Abstract] [Full Text] [Related]
27. Use of clonidine to decrease intestinal fluid losses in patients with high-output short-bowel syndrome. McDoniel K, Taylor B, Huey W, Eiden K, Everett S, Fleshman J, Buchman TG, Alpers D, Klein S. JPEN J Parenter Enteral Nutr; 2004 Dec; 28(4):265-8. PubMed ID: 15291409 [Abstract] [Full Text] [Related]
29. Plasma citrulline is not a biomarker for intestinal adaptation in short bowel syndrome, studied in piglets: a model for human neonates. Lansing M, Turner JM, Wizzard P, Lavallee CM, Lim DW, Muto M, Nation PN, Pencharz PB, Ball RO, Wales PW. Pediatr Surg Int; 2019 Jun 11; 35(6):657-663. PubMed ID: 30937511 [Abstract] [Full Text] [Related]
30. Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure. Jeppesen PB, Pertkiewicz M, Messing B, Iyer K, Seidner DL, O'keefe SJ, Forbes A, Heinze H, Joelsson B. Gastroenterology; 2012 Dec 11; 143(6):1473-1481.e3. PubMed ID: 22982184 [Abstract] [Full Text] [Related]
31. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group. Yeomans ND, Tulassay Z, Juhász L, Rácz I, Howard JM, van Rensburg CJ, Swannell AJ, Hawkey CJ. N Engl J Med; 1998 Mar 12; 338(11):719-26. PubMed ID: 9494148 [Abstract] [Full Text] [Related]
32. Reduced parenteral nutrition requirements following anastomosis of a short residual colonic segment to a short jejunum. Smith KH, Saunders JA, Nugent KP, Jackson AA, Stroud MA. JPEN J Parenter Enteral Nutr; 2011 Nov 12; 35(6):732-5. PubMed ID: 22042049 [Abstract] [Full Text] [Related]
33. Two and four weeks' treatment for duodenal ulcer. Symptom relief and clinical remission comparing omeprazole and ranitidine. Scandinavian Clinics for United Research. Glise H, Martinson J, Solhaug JH, Carling L, Unge P, Engström G, Hallerbäck B. Scand J Gastroenterol; 1991 Feb 12; 26(2):137-45. PubMed ID: 2011700 [Abstract] [Full Text] [Related]
34. Omeprazole and ranitidine in duodenal ulcer healing and subsequent relapse: a randomized double-blind study with weekly endoscopic assessment. Hui WM, Lam SK, Lau WY, Branicki FJ, Lok AS, Ng MM, Lai CL, Poon GP. J Gastroenterol Hepatol; 1989 Feb 12; 4 Suppl 2():35-43. PubMed ID: 2491360 [Abstract] [Full Text] [Related]
35. Pharmacotherapy and growth factors in the treatment of short bowel syndrome. Schwartz MZ, Kuenzler KA. Semin Pediatr Surg; 2001 May 12; 10(2):81-90. PubMed ID: 11329609 [Abstract] [Full Text] [Related]
36. Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders. McTavish D, Buckley MM, Heel RC. Drugs; 1991 Jul 12; 42(1):138-70. PubMed ID: 1718683 [Abstract] [Full Text] [Related]
37. Octreotide in dumping and short bowel syndromes. Farthing MJ. Digestion; 1993 Jul 12; 54 Suppl 1():47-52. PubMed ID: 8359568 [Abstract] [Full Text] [Related]
38. Growth hormone, glutamine, and a modified diet enhance nutrient absorption in patients with severe short bowel syndrome. Byrne TA, Morrissey TB, Nattakom TV, Ziegler TR, Wilmore DW. JPEN J Parenter Enteral Nutr; 1995 Jul 12; 19(4):296-302. PubMed ID: 8523629 [Abstract] [Full Text] [Related]
39. Double blind multicentre comparison of omeprazole 20 mg once daily versus ranitidine 150 mg twice daily in the treatment of cimetidine or ranitidine resistant duodenal ulcers. Delchier JC, Isal JP, Eriksson S, Soule JC. Gut; 1989 Sep 12; 30(9):1173-8. PubMed ID: 2680793 [Abstract] [Full Text] [Related]
40. Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. Jeppesen PB, Hartmann B, Thulesen J, Graff J, Lohmann J, Hansen BS, Tofteng F, Poulsen SS, Madsen JL, Holst JJ, Mortensen PB. Gastroenterology; 2001 Mar 12; 120(4):806-15. PubMed ID: 11231933 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]